Unable to provide a gene function summary for RFK (riboflavin kinase) based on the provided PubMed abstracts. The six abstracts supplied focus on obesity pharmacotherapy (semaglutide and tirzepatide trials), post-traumatic epilepsy, and blood-brain barrier dysfunction in neurodegeneration. None contain information about RFK gene function, mechanism, disease relevance, or clinical significance. To write an accurate, evidence-based summary grounded in PubMed literature, abstracts specifically addressing RFK biology, its role in flavin metabolism, TNF-induced ROS production, NADPH oxidase coupling, or RFK-associated diseases would be required.